Latest Early-onset Alzheimer's disease Stories
KIRKLAND, Wash., May 21 /PRNewswire/ -- Advana Science (www.advanascience.com) announced that Mark A. Smith, PhD, a leading researcher in Alzheimer's disease, has been named scientific advisor to the Company. According to the Journal of Alzheimer's Disease (Volume 16, Issue 3), Dr.
British researchers have developed a new drug against Alzheimer's disease they say has shown promise in tests on a handful of patients.
A recent study by Mount Sinai faculty suggests that a gene associated with onset of type-2 diabetes also decreases in Alzheimer's disease dementia cases.
A new report suggests the health care costs of Alzheimer's disease patients are more than triple those of other older people.
A study from the Buck Institute for Age Research offers a revolutionary new model for Alzheimerâ€™s disease (AD), a devastating neurodegenerative disorder which afflicts 24 million people worldwide.
WASHINGTON, Feb. 18 /PRNewswire-USNewswire/ -- The winners of the MetLife Foundation Awards for Medical Research in Alzheimer's Disease will be announced in Washington, D.C.
Researchers at Mayo Clinic have discovered the first gender-linked susceptibility gene for late-onset Alzheimer's disease.
Mutation of a gene that helps proteins migrate in and out of the cell's genetic command center â€“ the nucleus â€“ puts some families at higher risk for the degenerative brain disease acute necrotizing encephalopathy (ANE).
Scientists have new information about the complex genetic signature associated with Alzheimer's disease, the leading cause of cognitive decline and dementia in the elderly.
Researchers have found that two proteins which work in tandem in the brain's blood vessels present a double whammy in Alzheimer's disease.